Moffitt Cancer Center Leaders Highlight Importance of Cancer Research in D.C.

Leaders and researchers with Moffitt Cancer Center held face-to-face meetings with several senators and representatives in the nation’s capital today. The visit was part of a continuing effort to nurture the important relationship between the cancer center and the elected officials who ensure the mission of preventing and curing cancer remains obtainable through proper funding.

🏛️ The Moffitt team is here in D.C. with a mission! We'll meet with members of congress and ensure our voice is heard where it counts. The journey to making a difference continues! #MoffittDCFlyIn pic.twitter.com/Hht2nAX3MN

— Moffitt Cancer Center (@MoffittNews) September 16, 2025

Improving Outcomes

Karen Lu, MD

Over two days, representatives with Moffitt shared updates on Moffitt’s cutting-edge programs and innovations, emphasizing the impact of research and collaboration on improving outcomes for patients. Karen Lu, MD, physician in chief, highlighted Moffitt’s role as an expert in the field of cancer and provided the latest and most effective treatments.

“Moffitt is world renown for cancer immunotherapy,” Lu said, “and we have pioneered complex cell therapies that advance cancer care and provide more options for those we serve.”

CAR T Leader

Asmita Mishra, MD

Rep. Aaron Bean welcomed a Moffitt contingent and was curious about the latest and greatest cancer breakthroughs that have been spearheaded by Moffitt. Asmita Mishra, MD, was quick to highlight Moffitt’s work in CAR T-cell therapies.

“Moffitt is a leader in treating blood cancers by reprogramming a patient’s cells, treating them and reinfusing them back into the patient to combat cancer,” Mishra said. “Now that therapy is moving into the solid tumor space and it’s allowing us to reach even more patients.”

Federal Partnership Is Critical

Throughout the visit, conversations with members of congress gave Moffitt representatives a chance to highlight the importance of the federal government’s ongoing support to sustaining its mission. Many congress members were given the opportunity to learn how Moffitt is reaching out into the communities it serves through clinics that not only offer treatment, but access to clinical trials.

Valentina Ahumada contributed to this report.